QuidelOrtho Corporation

QuidelOrtho Corporation is a global in vitro diagnostics company providing diagnostic solutions across clinical laboratory, transfusion medicine, molecular testing, and point-of-care applications. The company offers over 550 assays across multiple testing modalities including real-time PCR, rapid lateral-flow immunoassays, automated immunohematology systems, and benchtop analyzers. Key product platforms include LYRA™ real-time PCR assays (open platform molecular testing), QUICKVUE™ rapid lateral-flow tests for infectious diseases and point-of-care diagnostics, TRIAGE™ System for point-of-care immunoassays, VITROS™ benchtop clinical chemistry systems, SOFIA™ 2 Analyzer for rapid diagnostics, ORTHO VISION™ Swift automated blood bank analyzers, ORTHO™ Workstation semi-automated immunohematology analyzer, and ORTHO OPTIX™ Reader for transfusion lab testing. The company serves clinical laboratories, hospitals, point-of-care settings, and home-testing markets in 140+ countries. QuidelOrtho recently completed acquisition of Lex Diagnostics, expanding its diagnostic portfolio. The company manufactures diagnostic instruments, reagents, and assays for infectious disease detection (virology, molecular, immunoassay), blood banking, clinical chemistry, and specialty testing. Products are regulated as in vitro diagnostic devices under FDA and international standards.